Company page

Aktis Oncology, Inc.

Aktis Oncology, Inc. is a public company traded under the ticker AKTS in the American market. The company has a market capitalization of approximately $1.33 billion. Aktis Oncology focuses on developing innovative cancer therapies to improve patient outcomes.

profileAKTS:NASDAQAI content: aiUpdated June 24, 2026/company/aktis-oncology-inc-common-stock/c-s4elkviy
Aktis Oncology, Inc. logo
Ticker
AKTS:NASDAQ
Asset type
Stock
Market cap
$1.33B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD